NATHAN REED: Open Payments
NPI 1467148536 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,739 in 99 payments from 23 companies in 2025. Trend: 2023 $1,087 · 2024 $1,688 · 2025 $1,739
Food & beverage: $1,739
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $269 |
| Lundbeck LLC | 11 | $196 |
| Otsuka America Pharmaceutical, Inc. | 8 | $151 |
| ARGENX US, INC. | 4 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $120 |
| Biogen, Inc. | 5 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $89 |
| Axsome Therapeutics, Inc. | 4 | $87 |
| Vanda Pharmaceuticals Inc. | 4 | $78 |
| Almatica Pharma LLC | 3 | $65 |
Products named: REXULTI, VRAYLAR, VYVGART HYTRULO, HYQVIA, VYEPTI, CAPLYTA, Auvelity, HETLIOZ.
Industry payments across SC — which companies pay providers there.
